Cabazitaxel vs docetaxel in chemotherapy-naive (CN) patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm phase III study (FIRSTANA).

Affiliation auteurs!!!! Error affiliation !!!!
TitreCabazitaxel vs docetaxel in chemotherapy-naive (CN) patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm phase III study (FIRSTANA).
Type de publicationJournal Article
Year of Publication2016
AuteursA. Sartor O, Oudard S, Sengelov L, Daugaard G, Saad F, Hansen S, Hjelm-Eriksson M, Jassem J, Thiery-Vuillemin A, Caffo O, Castellano DE, Mainwaring PN, Bernard JP, Shen L, Chadjaa M, Fizazi K
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.5006